357 related articles for article (PubMed ID: 27642059)
1. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
Grupper A; Grupper A; Daly RC; Pereira NL; Hathcock MA; Kremers WK; Cosio FG; Edwards BS; Kushwaha SS
J Heart Lung Transplant; 2017 Mar; 36(3):297-304. PubMed ID: 27642059
[TBL] [Abstract][Full Text] [Related]
2. Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: Analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.
Karamlou T; Welke KF; McMullan DM; Cohen GA; Gelow J; Tibayan FA; Mudd JM; Slater MS; Song HK
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):456-461.e1. PubMed ID: 24183335
[TBL] [Abstract][Full Text] [Related]
3. Renal function and outcome after heart transplantation.
Kolsrud O; Karason K; Holmberg E; Ricksten SE; Felldin M; Samuelsson O; Dellgren G
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1593-1604.e1. PubMed ID: 29338859
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.
Groetzner J; Kaczmarek I; Schulz U; Stegemann E; Kaiser K; Wittwer T; Schirmer J; Voss M; Strauch J; Wahlers T; Sohn HY; Wagner F; Tenderich G; Stempfle HU; Mueller-Ehmsen J; Schmid C; Vogeser M; Koch KC; Reichenspurner H; Daebritz S; Meiser B; Reichart B;
Transplantation; 2009 Mar; 87(5):726-33. PubMed ID: 19295318
[TBL] [Abstract][Full Text] [Related]
5. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplantation in patients with a prior heart transplant.
Cassuto JR; Reese PP; Bloom RD; Doyle A; Goral S; Naji A; Abt PL
Transplantation; 2010 Feb; 89(4):427-33. PubMed ID: 20177344
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
[TBL] [Abstract][Full Text] [Related]
8. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
Wang CS; Gander J; Patzer RE; Greenbaum LA
Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience.
Tokodai K; Amada N; Kikuchi H; Haga I; Takayama T; Nakamura A
Transplant Proc; 2012 Jan; 44(1):77-9. PubMed ID: 22310584
[TBL] [Abstract][Full Text] [Related]
10. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.
Groetzner J; Kaczmarek I; Landwehr P; Mueller M; Daebritz S; Lamm P; Meiser B; Reichart B
Eur J Cardiothorac Surg; 2004 Mar; 25(3):333-41. PubMed ID: 15019657
[TBL] [Abstract][Full Text] [Related]
11. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
12. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.
Chien CS; Luo HL; Ling CS; Chiang PH; Chen YT; Cheng YT
Int Urol Nephrol; 2016 Aug; 48(8):1261-1265. PubMed ID: 27193437
[TBL] [Abstract][Full Text] [Related]
13. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Doesch AO; Müller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Ehlermann P; Sack FU; Katus HA; Dengler TJ
Transplant Proc; 2010 Nov; 42(9):3694-9. PubMed ID: 21094840
[TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative renal replacement therapy on the clinical outcome of heart transplant patients.
Kim D; Choi JO; Cho YH; Sung K; Oh J; Cho HJ; Jung SH; Lee HY; Park JJ; Choi DJ; Kang SM; Kim JJ; Jeon ES
Sci Rep; 2021 Jun; 11(1):13398. PubMed ID: 34183719
[TBL] [Abstract][Full Text] [Related]
15. The survival benefit of simultaneous heart-kidney transplantation extends beyond dialysis-dependent patients.
Kilic A; Grimm JC; Whitman GJ; Shah AS; Mandal K; Conte JV; Sciortino CM
Ann Thorac Surg; 2015 Apr; 99(4):1321-7. PubMed ID: 25707587
[TBL] [Abstract][Full Text] [Related]
16. De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results.
Meiser B; Buchholz S; Kaczmarek I
Curr Opin Organ Transplant; 2011 Oct; 16(5):522-8. PubMed ID: 21836511
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
18. Pediatric heart transplantation: 23-year single-center experience.
Huebler M; Schubert S; Lehmkuhl HB; Weng Y; Miera O; Alexi-Meskishvili V; Berger F; Hetzer R
Eur J Cardiothorac Surg; 2011 May; 39(5):e83-9. PubMed ID: 21354807
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification for renal transplantation after cardiac or lung transplantation: single-center experience and review of the literature.
Rosenberger C; Stein J; Jürgensen JS; Eibl N; Babel N; Bachmann U; Kemper D; Knosalla C; Hetzer R; Frei U; Lehmkuhl H; Reinke P
Kidney Blood Press Res; 2007; 30(4):260-6. PubMed ID: 17622737
[TBL] [Abstract][Full Text] [Related]
20. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
